The US approves Eli Lilly for diabetes

The U.S. Food and Drug Administration said it has approved Eli Lilly’s injectable Mounjaro, an injectable drug called tirzepatide, to improve blood sugar control in adults with type 2 diabetes.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner